Experimental study progress of smoking- and alcohol-induced osteoporosis

Abstract

CLC Number:

R681

LI Xiaoli, SHA Nannan, CHEN Nan, WANG Yongjun, ZHANG Yan. Experimental study progress of smoking- and alcohol-induced osteoporosis[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(11): 1299-1303.

References

［1］Malik P, Gasser RW, Kemmler G, et al. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study［J］. Alcohol Clin Exp Res, 2009, 33(2): 375-381.
［2］Bijelic R, Milicevic S, Balaban J. Risk factors for osteoporosis in postmenopausal women ［J］. Med Arch, 2017, 71(1): 25-28.
［3］Yoon V, Maalouf NM, Sakhaee K. The effects of smoking on bone metabolism［J］. Osteoporos Int, 2012, 23(8): 2081-2092.
［4］Fusby JS, Kassmeier MD, Palmer VL, et al. Cigarette smoke-induced effects on bone marrow B-cell subsets and CD4+:CD8+T-cell ratios are reversed by smoking cessation: Influence of bone mass on immune cell response to and recovery from smoke exposure［J］. Inhal Toxicol, 2010, 22(9): 785-796.
［5］Cielen N, Maes K, Heulens N, et al. Interaction between physical activity and smoking on lung, muscle, and bone in mice［J］. Am J Respir Cell Mol Biol, 2016, 54(5): 674-682.
［6］Franco GR, Laraia IO, Maciel AA, et al. Effects of chronic passive smoking on the regeneration of rat femoral defects filled with hydroxyapatite and stimulated by laser therapy［J］. Injury, 2013, 44(7): 908-913.
［7］雷光华, 高曙光, 覃芙, 等. 骨桥蛋白基因反义寡核苷酸对被动吸烟大鼠骨组织的影响［J］. 中国药理学与毒理学杂志, 2009, 23(5): 395-403.
［8］Iwaniec UT, Fung YK, Akhter MP, et al. Effects of nicotine on bone mass, turnover, and strength in adult female rats［J］. Calcif Tissue Int, 2001, 68(6): 358-364.
［9］Akhter MP, Iwaniec UT, Haynatzki GR, et al. Effects of nicotine on bone mass and strength in aged female rats［J］. J Orthop Res, 2003, 21(1): 14-19.
［10］Ko CH, Chan RL, Siu WS, et al. Deteriorating effect on bone metabolism and microstructure by passive cigarette smoking through dual actions on osteoblast and osteoclast［J］. Calcif Tissue Int, 2015, 96(5): 389-400.
［11］Gao SG, Li KH, Xu M, et al. Bone turnover in passive smoking female rat: relationships to change in bone mineral density［J］. BMC Musculoskelet Disord, 2011, 12: 131.
［12］Wang D, Nasto LA, Roughley P, et al. Spine degeneration in a murine model of chronic human tobacco smokers［J］. Osteoarthritis Cartilage, 2012, 20(8): 896-905.
［13］Iqbal J, Sun L, Cao J, et al. Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes［J］. Proc Natl Acad Sci U S A, 2013, 110(27): 11115-11120.
［14］Ma D, Li Y, Hackfort B, et al. Smoke-induced signal molecules in bone marrow cells from altered low-density lipoprotein receptor-related protein 5 mice［J］. J Proteome Res, 2012, 11(7): 3548-3560.
［15］张楠楠, 谭亚荣, 张姗姗, 等. 酒精与骨骼［J］. 中国骨质疏松杂志, 2014, 20(7): 141-145.
［16］Cruel M, Granke M, Bosser C, et al. Chronic alcohol abuse in men alters bone mechanical properties by affecting both tissue mechanical properties and microarchitectural parameters［J］. Morphologie, 2017,101(333)88-96.
［17］Tardelli VS, Lago MP, Silveira DX, et al. Vitamin D and alcohol: A review of the current literature［J］. Psychiatry Res, 2017, 248: 83-86.
［18］Alvisa-Negrin J, Gonzalez-Reimers E, Santolaria-Fernandez F, et al. Osteopenia in alcoholics: effect of alcohol abstinence［J］. Alcohol, 2009, 44(5): 468-475.
［19］Schnitzler CM, Mesquita JM, Shires R. Cortical and trabecular bone microarchitecture and turnover in alcohol-induced chronic pancreatitis: a histomorphometric study［J］. J Bone Miner Metab, 2010, 28(4): 456-467.
［20］Mercer KE, Wynne RA, Lazarenko OP, et al. Vitamin D supplementation protects against bone loss associated with chronic alcohol administration in female mice［J］. J Pharmacol Exp Ther, 2012, 343(2): 401-412.
［21］Ren SJ, Xing GL, Hu NW, et al. Bu-Shen-Jian-Pi-Yi-Qi therapy prevents alcohol-induced osteoporosis in rats［J］. Am J Ther, 2016, 23(5): e1135-1142.
［22］丛洪飞, 梁惠, 戈娜, 等. 熊果酸对酒精性骨质疏松大鼠骨形成、骨矿化的影响［J］. 现代生物医学进展, 2017, 17 (2): 220-224.
［23］Broulík PD, Vondrová J, Rüzicka P, et al. The effect of chronic alcohol administration on bone mineral content and bone strength in male rats［J］. Physiol Res, 2010, 59(4): 599-604.
［24］Johnson TL, Gaddini G, Branscum AJ, et al. Effects of chronic heavy alcohol consumption and endurance exercise on cancellous and cortical bone microarchitecture in adult male rats［J］. Alcohol Clin Exp Res, 2014, 38(5): 1365-1372.
［25］Chavassieux P, Serre CM, Vergnaud P, et al. In vitro evaluation of dose-effects of ethanol on human osteoblastic cells［J］. Bone Miner, 1993, 22(2): 95-103.
［26］Wang Y, Li Y, Mao K, et al. Alcohol induced adipogenesis in bone and marrow: a possible mechanism for osteonecrosis［J］. Clin Orthop Relat Res, 2003, 410: 213-224.
［27］孙太存, 丁亮, 黄永辉, 等. 酒精诱导体外培养成骨细胞凋亡及Bcl-2、Bax mRNA表达的实验研究［J］. 中国骨质疏松杂志, 2009, 15(4): 27-32.
［28］Bonewald LF, Johnson ML. Osteocytes, mechanosensing and Wnt signaling［J］. Bone, 2008, 42(4): 606-615.
［29］Chen JR, Lazarenko OP, Shankar K, et al. A role for ethanol-induced oxidative stress in controlling lineage commitment of mesenchymal stromal cells through inhibition of Wnt/beta-catenin signaling［J］. J Bone Miner Res, 2010, 25(5): 1117-1127.
［30］Howe KS, Iwaniec UT, Turner RT. The effects of low dose parathyroid hormone on lumbar vertebrae in a rat model for chronic alcohol abuse［J］. Osteoporos Int, 2011, 22(4): 1175-1181.
［31］Hoang M, Kim JJ, Kim Y, et al. Alcohol-induced suppression of KDM6B dysregulates the mineralization potential in dental pulp stem cells［J］. Stem Cell Res, 2016, 17(1): 111-121.
［32］Chen X, Li M, Yan J, et al. Alcohol induces cellular senescence and impairs osteogenic potential in bone marrow-derived mesenchymal stem cells［J］. Alcohol Alcohol, 2017, 25:1-9.
［33］Liu Y, Kou X, Chen C, et al. Chronic high dose alcohol induces osteopenia via activation of mTOR signaling in bone marrow mesenchymal stem cells［J］. Stem Cells, 2016, 34(8): 2157-2168.
［34］Leu YW, Chu PY, Chen CM, et al. Early life ethanol exposure causes long-lasting disturbances in rat mesenchymal stem cells via epigenetic modifications［J］. Biochem Biophys Res Commun, 2014, 453(3): 338-344.
［35］Menagh PJ, Turner RT, Jump DB, et al. Growth hormone regulates the balance between bone formation and bone marrow adiposity［J］. J Bone Miner Res, 2010, 25(4): 757-768.
［36］Turner RT, Rosen CJ, Iwaniec UT. Effects of alcohol on skeletal response to growth hormone in hypophysectomized rats［J］. Bone, 2010, 46(3): 806-812.
［37］Maddalozzo GF, Turner RT, Edwards CH, et al. Alcohol alters whole body composition, inhibits bone formation, and increases bone marrow adiposity in rats［J］. Osteoporos Int, 2009, 20(9): 1529-1538.
［38］González-Reimers E, Alvisa-Negrín J, Santolaria-Fernández F, et al. Prognosis of osteopenia in chronic alcoholics［J］. Alcohol, 2011, 45(3): 227-238.

[1]	WANG Donghui, JIANG Suwen, HU Airong, ZHU Bo, HE Zheyun, ZHANG Lukan, WANG Jialan, FAN Ying, LIN Ken . Mulberry exerts antioxidant stress effect in rats with nonalcoholic fatty liver disease [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 609-616.
[2]	CAI Zuhuan, DENG Taomei, WEI Naijie, ZHU Dan, QIAN Fei, WANG Guangji, ZHANG Jingwei. Silybin ameliorates lipid metabolism disorders in mice with non-alco-holic steatohepatitis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 241-248.
[3]	ZHAO Yangting, CHEN Chongyang, PAN Binjing, LV Xiaoyu, LIU Jingfang. Trimethylamine N-oxide: the potential target for osteoporosis treatment [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1161-1167.
[4]	MA Shen, LIU Yushuo, TANG Hui, CHEN Wenbin, GAO Ling. Pharmacokinetics and clinical significance of drugs for improving nonalcoholic fatty liver disease [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 908-918.
[5]	YE Sen, CHEN Yanzhen, LAI Liping, ZHONG Lingjian, YU Changzhang. Comparison on the efficacy and safety of ultrasound-guided and X-ray guided for needle approach of percutaneous vertebroplasty [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 551-557.
[6]	DU Chen, TIAN He, CAO Yang, WANG Yongjun, ZHANG Yan. Research progress on bone metabolism disorders associated with PCOS elucidated from endocrine hormones [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 328-333.
[7]	ZHANG Liang, LIAO Yongqun, XIA Qinchuan, ZHOU Shitong, LI Xiaoli. Ferroptosis regulatory signaling pathway and its research progress in related diseases [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 227-234.
[8]	SONG Ruzheng, PENG Ying, WANG Guangji, SUN Jianguo. Commonly used quantitative proteomics research techniques and their application in the study of pathogenesis of liver-derived diseases [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 570-578.
[9]	WU Jiayuan, ZHENG Li, MO Juanfen, GUO Li, CAO Chenxi, BAO Yi. Regulation of N-acetylcysteine on peripheral circulatory and hepatic myeloid-derived suppressor cells in non-alcoholic fatty liver disease mice [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 989-996.
[10]	CHEN Xi, LING Jiawei, DING Jiaxin, JIANG Zhenzhou, ZHANG Luyong. Advances in pathogenesis of nonalcoholic fatty liver disease caused by tamoxifen [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(6): 715-720.
[11]	ZHOU Hongping, YANG Xingxin, ZHUANG Rangxiao, SHAO Yidan, XI Jianjun, LIAO Li, REN Bailu, WANG Pingping, YU Shuying, SHI Tingting. Effects of activated carbon N-acetylcysteine sustained-release microcapsule on miRNA of non-alcoholic fatty liver disease in young rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(3): 263-270.
[12]	DENG Zuyue, HUANG Junjun. Healing effect of Xianling Gubao plus probiotics on osteoporotic fracture rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(10): 1126-1131.
[13]	YANG Yilin, ZHENG Linying, GU Weiming, PAN Jingqiang, WU Xin，LI Yaojun. Effect of total glucosides of paeony regulate HMGB1, RAGE pathway on nonalcoholic fatty liver disease in rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 611-616.
[14]	YU Qinyun, SU Xiaogong, BAO Qiying, CHEN Xiaoyan. Effect of resveratrol on the Wnt/β-Catenin pathway in ovariectomized osteoporosis rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 645-649.
[15]	CHEN Dan, LIN Xiuxian, CHEN Yao. Research on the progress of alcoholic liver disease pathogenesis related to CYP2E1 [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(2): 198-203.